Table 2.
Cancer control continuum and content | Android (n=41), n (%) | iOS (n=28), n (%) | Total (n=69), n (%) | |
Etiology and prevention | ||||
|
Information on BC | 19 (46.3) | 9 (32.1) | 28 (40.6) |
|
Risk prediction | 8 (19.5) | 2 (7.1) | 10 (14.5) |
|
Education for prevention and risk factors for BC | 16 (39.0) | 6 (21.4) | 22 (31.9) |
Detection | ||||
|
Guidance for early detection | 21 (51.2) | 13 (46.4) | 34 (49.3) |
|
Connection to professionals | 5 (12.2) | 5 (17.9) | 10 (14.5) |
Diagnosis and treatment | ||||
|
Information on BC treatment | 17 (41.5) | 10 (35.7) | 27 (39.1) |
|
PGHDa | 8 (19.5) | 11 (39.3) | 19 (27.5) |
|
Medical records | 4 (9.8) | 2 (7.1) | 6 (8.7) |
|
Medication management | 7 (17.1) | 9 (32.1) | 16 (23.2) |
|
Consultation by a physician | 3 (7.3) | 1 (3.6) | 4 (5.8) |
|
Tracking appointments | 4 (9.8) | 5 (17.9) | 9 (13.0) |
|
Participation in decision-making | 5 (12.2) | 4 (14.3) | 9 (13.0) |
Survivorship | ||||
|
Information on posttreatment care and prevention of recurrence | 8 (19.5) | 6 (21.4) | 14 (20.3) |
|
Education for lifestyle modification | 15 (36.6) | 7 (25.0) | 23 (33.3) |
|
Consultation with an expert | 6 (14.6) | 4 (14.3) | 10 (14.5) |
|
Psychological support | 7 (17.1) | 10 (35.7) | 17 (24.6) |
|
Community | 7 (17.1) | 6 (21.4) | 13 (18.8) |
|
Sharing information with family and caregivers | 5 (12.2) | 2 (7.1) | 7 (10.1) |
|
Fundraising | 3 (7.3) | 5 (17.9) | 8 (11.6) |
aPGHD: patient-generated health data.